Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure. | Zendy

Stephen S. Gottlieb | Zendy; Kenneth Dickstein | Zendy; Eckart Fleck | Zendy; John B. Kostis | Zendy; T. Barry Levine | Zendy; Thierry H. LeJemtel | Zendy; M. Dekock | Zendy

Open Access

Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure.

Author(s) -

Stephen S. Gottlieb,

Kenneth Dickstein,

Eckart Fleck,

John B. Kostis,

T. Barry Levine,

Thierry H. LeJemtel,

M. Dekock

Publication year - 1993

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/01.cir.88.4.1602

Subject(s) - losartan , medicine , heart failure , angiotensin ii , vasodilation , hemodynamics , cardiology , angiotensin ii receptor antagonist , blood pressure

Losartan is a new specific angiotensin II receptor antagonist with no agonist properties that provides the opportunity to study the consequences of angiotensin II blockade. The objective of the present study was to evaluate the hemodynamic and neurohormonal response to losartan in patients with congestive heart failure.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research